Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hourmant

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Transplantation|January 1, 1994
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplantation Proceedings|August 1, 1991
Maintenance immunosuppression without corticosteroids following combined pancreas and kidney transplantationD Cantarovich, J Palneau, J P Couderc, et al.
Transplantation|December 15, 1995
Late acute failure of well-HLA-matched renal allografts with capillary congestion and arteriolar thrombiM Hourmant, F Buzelin, J Dantal, et al.
Nephrologie & Therapeutique|November 2, 2013
[20% of living donor kidney transplantation in France? Yes, it's possible!]C Chauvet, P Chauveau, M Hourmant, et al.
The Journal of Hospital Infection|January 21, 2015
Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospitalB Semin-Pelletier, L Cazet, C Bourigault, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 11, 2012
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantationJ Zuber, M Le Quintrec, S Krid, et al.
Transplantation Proceedings|January 3, 2001
What is the value of procurement biopsy lipid peroxidation lesions in the assessment of kidney graft function?G Benoit, V Paradis, S Droupy, et al.
Transplantation Proceedings|August 1, 1997
An open multicenter trial of conversion from Sandimmun to Neoral in stable kidney-transplant patientsM Hourmant, C Antoine, F Bayle, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Transplantation|January 1, 1994
Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantationD Cantarovich, B Le Mauff, M Hourmant, et al.
Transplantation Proceedings|August 1, 1991
Maintenance immunosuppression without corticosteroids following combined pancreas and kidney transplantationD Cantarovich, J Palneau, J P Couderc, et al.
Transplantation|December 15, 1995
Late acute failure of well-HLA-matched renal allografts with capillary congestion and arteriolar thrombiM Hourmant, F Buzelin, J Dantal, et al.
Nephrologie & Therapeutique|November 2, 2013
[20% of living donor kidney transplantation in France? Yes, it's possible!]C Chauvet, P Chauveau, M Hourmant, et al.
The Journal of Hospital Infection|January 21, 2015
Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospitalB Semin-Pelletier, L Cazet, C Bourigault, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 11, 2012
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantationJ Zuber, M Le Quintrec, S Krid, et al.
Transplantation Proceedings|January 3, 2001
What is the value of procurement biopsy lipid peroxidation lesions in the assessment of kidney graft function?G Benoit, V Paradis, S Droupy, et al.
Transplantation Proceedings|August 1, 1997
An open multicenter trial of conversion from Sandimmun to Neoral in stable kidney-transplant patientsM Hourmant, C Antoine, F Bayle, et al.
The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.
Pageof 10